Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
If the device has been refrigerated, allow it to reach room temperature for the period specified in your trial instructions before injecting, as this may reduce discomfort
For those using it specifically for weight loss, note that discontinuation may result in regaining any lost weight, and there may also be severe side effects necessitating its discontinuation
Our team will evaluate your goals and recommend the most effective treatment plan for you
Medicaid coverage varies widely across states California offers coverage, while Texas does not
Receptor Grade IGF-1 LR3 Peptide and Cellular Hypertrophy Studies by Thomas et al
In March 2026, Roche reported that the Phase 2 ZUPREME-1 trial produced mean body-weight reductions of up to 10.7% at week 42 versus 1.7% with placebo under the reported analysis
